Rich Aidan Lindsay Fenner, Cook Jillianne Leigh, Hahne Andrew John, Ford Jon Joseph
School of Allied Health, Human Services and Sport, La Trobe University, Plenty Road, Bundoora, VIC, 3086, Australia.
Advance Healthcare, 157 Scoresby Road, Boronia, VIC, 3155, Australia.
J Exp Orthop. 2023 May 25;10(1):55. doi: 10.1186/s40634-023-00615-x.
Proximal hamstring tendinopathy (PHT) presents as localised lower buttock pain with tasks such as squatting and sitting. It is a condition that occurs at all ages and levels of sporting participation and can cause disability with sport, work, and activities of daily living. This paper details a pilot trial protocol for investigating the effectiveness of individualised physiotherapy compared to extracorporeal shockwave therapy (ESWT) on pain and strength in people with PHT.
The study is an assessor-blinded, pilot randomised controlled trial (RCT). One hundred participants with PHT will be recruited from the local community and sporting clubs. Participants will be randomised to receive six sessions of either individualised physiotherapy or ESWT, with both groups also receiving standardised education and advice. Primary outcomes will be global rating of change on a 7-point Likert scale, and the Victorian Institute of Sport-Hamstring (VISA-H) scale, measured at 0, 4, 12, 26 and 52 weeks. Secondary outcomes will include sitting tolerance, the modified Physical Activity Level Scale, eccentric hamstring strength, modified Tampa scale for kinesiophobia, the Örebro Musculoskeletal Pain Screening Questionnaire Short Form (ÖMPSQ-SF), Numerical Pain Rating Scale (NPRS) for average and worst pain, participant adherence, the Pain Catastrophizing scale, satisfaction scores, and quality of life. Data will be analysed on an intention to treat basis, with between-group effects estimated using linear mixed models for continuous data and Mann Whitney U tests for ordinal data.
This pilot RCT will compare individualised physiotherapy versus ESWT for PHT. The trial will determine feasibility and estimated treatment effects to inform a definitive trial in the future.
The trial has been prospectively registered with the Australia & New Zealand Clinical Trials Registry (ACTRN12621000846820), registered 1 July 2021, https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373085.
近端腘绳肌腱病(PHT)表现为在深蹲和坐下等动作时出现臀部下方局部疼痛。这种病症在所有年龄段以及不同运动参与水平的人群中均有发生,并且会导致在运动、工作及日常生活活动中出现功能障碍。本文详细介绍了一项试验性试验方案,旨在研究个体化物理治疗与体外冲击波疗法(ESWT)相比,对PHT患者疼痛和力量的影响。
该研究为评估者盲法、试验性随机对照试验(RCT)。将从当地社区和体育俱乐部招募100名PHT患者。参与者将被随机分配接受六次个体化物理治疗或ESWT,两组同时还将接受标准化教育和建议。主要结局指标为在0、4、12、26和52周时,采用7点李克特量表进行的总体变化评分以及维多利亚运动学院腘绳肌(VISA-H)量表评分。次要结局指标将包括坐位耐受时间、改良的身体活动水平量表、腘绳肌离心力量、改良的坦帕运动恐惧量表、Örebro肌肉骨骼疼痛筛查问卷简表(ÖMPSQ-SF)、平均和最严重疼痛的数字疼痛评分量表(NPRS)、参与者依从性、疼痛灾难化量表、满意度评分以及生活质量。数据将按照意向性分析原则进行分析,对于连续数据,采用线性混合模型估计组间效应;对于有序数据,采用曼-惠特尼U检验。
这项试验性RCT将比较PHT患者的个体化物理治疗与ESWT。该试验将确定可行性和估计的治疗效果,为未来的确定性试验提供依据。
该试验已在澳大利亚和新西兰临床试验注册中心(ACTRN12621000846820)进行前瞻性注册,注册时间为2021年7月1日,网址为https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373085 。